Recent share performance and business profile

National Health Investors (NHI) has drawn investor attention after its stock rose about 3% in the latest session, even as it is down around 5% over the past month and 17% over the past 3 months.

The company is a self managed real estate investment trust focused on senior housing and medical facilities. Its portfolio includes independent living, assisted living, memory care communities, skilled nursing facilities and specialty hospitals.

National Health Investors reports revenue of US$404.7m and net income of US$147.9m, with activities mainly in the United States and contributions from both real estate investment and SHOP operations.

At a share price of US$70.43, National Health Investors has seen recent momentum soften, with the share price declining over the past quarter, even as longer term total shareholder returns over 3 and 5 years remain positive.

The recent 1 day share price gain of 3.09% follows a period in which the 90 day share price return declined 16.77% and the year to date share price return fell 8.35%. This suggests investors are reassessing the balance between income potential and perceived risk in senior housing and healthcare real estate.

If you are comparing NHI with other income focused or defensive ideas, it can be useful to look at how different business models and balance sheets behave through similar swings in sentiment.

To widen your search beyond healthcare REITs, this could be a good moment to scan for companies exposed to long term infrastructure themes using our 33 power grid technology and infrastructure stocks

With NHI trading at US$70.43 and an analyst price target of US$85.75, alongside an intrinsic value estimate at a sizeable discount, you have to ask: is this a genuine value opportunity, or is the market already pricing in future growth?

Most Popular Narrative: 18% Undervalued

With National Health Investors trading at $70.43 against a widely followed fair value narrative of $85.75, the current market price sits well below that central estimate, which puts the focus squarely on the assumptions behind that gap.

Accelerating growth in the 75+ U.S. population and increased demand for senior housing are driving higher occupancy rates and pricing power in NHI's SHOP portfolio, evidenced by recent quarter over quarter rises in both occupancy and RevPOR. This is expected to support sustained revenue and net operating income (NOI) growth.

Want to see what is built into that valuation gap? The narrative leans on steady revenue expansion, firm margins and a future earnings multiple that assumes the story keeps playing out. The exact mix of growth and profitability expectations might surprise you.

Result: Fair Value of $85.75 (UNDERVALUED)

However, there are still pressure points to watch, including tenant concentration around key operators and reliance on equity issuance, which could weigh on per share results.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

Next Steps

With the mix of optimism and concern running through this story, it makes sense to check the numbers yourself and move quickly to your own view. You can start with our breakdown of 4 key rewards and 2 important warning signs.

Looking for more investment ideas?

If you stop here, you miss a wider set of opportunities that could fit your goals better than a single stock, so keep expanding your watchlist.

• Target steadier potential returns by scanning companies that focus on dependable payouts using the 9 dividend fortresses.
• Hunt for quality at a reasonable price by checking stocks that appear mispriced on fundamentals through the 49 high quality undervalued stocks.
• Strengthen your core holdings by reviewing companies with robust finances using the solid balance sheet and fundamentals stocks screener (46 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.